The Bruker Microbiology & Infection Diagnostics division has announced the European launch of its MyGenius PRO automated ...
Marks a Milestone in QuidelOrtho's Plans to Accelerate Growth in Point-of-Care Molecular Diagnostics –– Expands Portfolio with Ultra-Fast PCR Platform Designed to Deliver Results in Approximately Ten ...
Canadians are hospitalized with bloodstream infections each year. New findings show fast diagnostics could prevent 2,400 of ...
The SYNLAB Nigeria approach to global standards and improved patient outcomes.advertisement In Nigeria’s healthcare system, ...
At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division (Bruker Corporation, Nasdaq: BRKR) announces ...
New addition to state’s veterinary lab system will speed animal disease diagnoses, lowering business costs and helping ...
A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial intelligence (AI) pathology ...
Genetrack Biolabs, working in partnership with Canada's Michael Smith Genome Sciences Centre as part of a landmark research–industry collaboration, has announced the development of a revolutionary ...
Q1 2026 Earnings Call April 21, 2026 8:00 AM EDTCompany ParticipantsRachel VatnsdalRainer Blair - President, CEO ...
Spending more time managing your health in your 70s and beyond is part of the “new normal” of extending healthy longevity to ...
TTP today announced the acquisition by QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, of LEX Diagnostics Limited, a UK-based molecular diagnostics company and a spin- ...
Edmonton Journal on MSNOpinion
Lorne Gunter: Private access to diagnostic tests reduces burden on public health care
Raise your arms over your head and run around the room frantically waving your hands and shrieking, “It will destroy public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results